The Galleri® test
The Galleri test detects more than 50 types of cancer through a simple blood draw.1

Key benefits of the Galleri test

Early cancer detection

Detects many cancers not commonly screened for today, to allow for earlier treatment.1,2

Testing with ease

Completed with a simple blood draw.

Actionable results

If a cancer signal is found, the results can point to where in the body the cancer is coming from with high accuracy.

Who can benefit

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test is intended to be used in addition to, and not replace, other cancer screening tests your healthcare provider recommends.

The Galleri test does not detect all cancers, nor does it measure your genetic risk of developing cancer in the future.

Request the Galleri test

The process begins by requesting the test from a healthcare provider.

FAQs about the Galleri test

The Galleri test looks for signals present in the blood that may be associated with cancer at the time of your blood draw. If a cancer signal is detected, Galleri results can point to where in the body the cancer is coming from to help your healthcare provider guide next steps.

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older.

The Galleri test is intended to be used in addition to, and not replace, other cancer screening tests your healthcare provider recommends.

Family history is only one of many risk factors associated with cancer development. These risk factors include eating habits, lifestyle, living or working environments, genetics, and many others.1 Talk to your healthcare provider to determine whether the Galleri test is right for you.

In a large-scale, clinical validation sub-study of CCGA, the Galleri test detected more than 50 cancer types across all stages.

Sign up for more information about the Galleri test

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167 – 1177. doi: 10.1016/j.annonc.2021.05.806.
  2. The Galleri test does not detect all cancers, nor does it measure your genetic risk of developing cancer in the future. It should be used in addition to routine screening tests your healthcare provider recommends.
  3. Data source: U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2019 submission data (1999−2017): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; www​.cdc​.gov/​c​a​n​c​e​r​/​d​a​taviz, released in June 2020.